China's Sinopharm vaccine receives 1st EU GMP certificate

26 374
3.5%
CGTN2.5M
Published on 5 Apr 2021, 4:13
For more:
news.cgtn.com/news/2021-04-05/...

The China National Pharmaceutical Group Co., Ltd. (Sinopharm) announced on Saturday that its COVID-19 vaccine has acquired the GMP certificate issued by the Hungarian National Institute of Pharmacy and Nutrition (OGYEI), becoming the first Chinese COVID-19 vaccine to receive such a certificate.

With a Chinese COVID-19 vaccine receiving the first Good Manufacturing Practice (GMP) certificate issued by the Hungarian authorities, Chinese jabs are reportedly a step closer to becoming a global public good. At least 100 million doses of COVID-19 vaccines from Sinopharm have been supplied around the world.

Subscribe to us on YouTube: goo.gl/lP12gA
Download our APP on Apple Store (iOS): itunes.apple.com/us/app/cctvne...
Download our APP on Google Play (Android): play.google.com/store/apps/det...
newsautotechmusickids